Coming on the heels of announcing a study to test a device focused on helping Parkinson’s patients, French drug delivery company Biocorp has unveiled its newest sensor that connects inhalers to devices like smartphones and tablets for people suffering from asthma or COPD.
Dubbed Inspair, the device can record data gathered each time an inhaler is used and can relay that information to care-givers while also telling the user if they are using the device correctly. Inspair has miniaturized sensors and an electronic card, and can fit on most inhaler mouthpieces by using special adaptors.
The debut of Inspair comes about a week after Biocorp announced that its Easylog connecting device will be teamed with Aguettant’s Apokinon apomorphine self-injection pen in a 19-month study to gather data about Parkinson’s patients’ symptoms and treatments via smartphone or tablet.
“Significant applications have been developed in diabetology, endocrinology and neurology with the Datapen and Easylog devices, and our new sensor Inspair also positions us in the area of chronic lung diseases which affect an increasing number of people in need of new solutions to improve compliance,” Jacques Gardett, Biocorp’s chief executive, said in a statement.
Biocorp is focused on developing data-wiring instruments like the internet-connected DataPen for recording insulin injection on a mobile app or add-ons that accomplish the same task with existing delivery devices.
- check out the release